Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mahboobeh Naderi, Nasab"'
Autor:
Mohammad Derakhshan, Mehrangiz Khaje-Karamadini, Zahra Meshkat, Mahboobeh Naderi Nasab, Maryam Sadat Nabavinia
Publikováno v:
Cell Journal, Vol 14, Iss 1, Pp 61-66 (2012)
Objective: Despite using the Bacille Calmette Guerin (BCG) vaccine, tuberculosis (TB) is still a worldwide disease that kills 2-3 million people each year. Developing a new and more effective vaccine is one way to possibly reduce the morbidity and mo
Externí odkaz:
https://doaj.org/article/d4eca188d7c14b61b821c9d20c0b2a85
Autor:
Mahboobeh Naderi-Nasab, AliAkbar Heydari, Valyolah Booryazadeh, Ahmadreza Zarifian, Zahra Meshkat, Monavar Afzalaghaei
Publikováno v:
Journal of Medical Bacteriology, Vol 3, Iss 3-4 (2015)
Introduction: Staphylococcus aureus colonization has been recognized as one of the most important risk factors for subsequent infections with this microorganism. In this study, we intended to identify all patients who were MRSA-positive upon admissio
Externí odkaz:
https://doaj.org/article/673ad8a8b81e45088281cd146d50e8e4
Publikováno v:
Journal of Medical Bacteriology, Vol 1, Iss 3-4 (2015)
Background: Staphylococcus aureus is a major human pathogen world wide. Vancomycin has been used for decades to treat multidrug resistant S. aureus. Ten years has passed since the first report of vancomycin re sistant S. aureus (VRSA). The objective
Externí odkaz:
https://doaj.org/article/1f414e02855c4e27a502dc230dbcd18c
Publikováno v:
Iranian Journal of Microbiology, Vol 6, Iss 2 (2014)
Background and Objective: Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is increasingly reported worldwide. We aimed to determine the frequency of invasive CA-MRSA in children admitted to the pediatric wards of Imam Reza an
Externí odkaz:
https://doaj.org/article/f806a95cc5354cb1b75e5b9f0190e397
Publikováno v:
Infectious Diseases in Clinical Practice. 21:91-93
At the 10th anniversary of the first report of vanA vancomycin-resistant Staphylococcus aureus (VRSA), we aimed to determine the total number of vanA-VRSA reported in the literature. Relevant key words were used to search through PubMed, Sciverse, an
Publikováno v:
Journal of Medical Bacteriology, Vol 1, Iss 2 (2013)
Journal of Medical Bacteriology, Vol 1, Iss 3-4 (2015)
Journal of Medical Bacteriology, Vol 1, Iss 3-4 (2015)
Background: Staphylococcus aureus is a major human pathogen worldwide. Vancomycin has been used for decades to treat multidrug resistant S. aureus. Ten years has passed since the first report of vancomycin resistant S. aureus (VRSA). The objective
Autor:
Fatemeh Estaji, Mahboobeh Naderi Nasab, Zahra Moravvej, Sareh Saadat, Emran Askari, Kavous Solhjou
Publikováno v:
International journal of antimicrobial agents. 42(4)
Autor:
Maryam Sadat, Nabavinia, Mahboobeh Naderi, Nasab, Zahra, Meshkat, Mohammad, Derakhshan, Mehrangiz, Khaje-Karamadini
Publikováno v:
Avicenna Journal of Medical Biotechnology
Expressions of recombinant proteins for different applications are important objectives in molecular biotechnology; however, expression of some recombinant proteins is difficult. Several methods have been designed for expression of these proteins. Th